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Abstract
We report on a preanalytical issue we encountered during routine clinical chemistry analyses, potentially leading to deviated analysis results and 
believe that it might help other laboratories to overcome similar problems. In a heparin-gel tube we measured an implausible glucose value of 0.06 
mmol/L. Re-measurement of the same sample resulted in a glucose value of 5.4 mmol/L. After excluding an analytical error, we inspected the sam-
ple closer and found a white material as well as fatty droplets floating on the surface of the plasma tube. Evaluation of these structures revealed that 
the white particulate matter (WPM) consisted of fibrinogen, platelets and leukocytes and the fatty droplets most probably originated from the se-
parator gel. We concluded that these structures formed a temporary clot in the instruments pipetting needle thereby altering the sampling volume 
and subsequently the measured glucose value. The formation of WPM might be attributable to high speed centrifugation, high cholesterol levels, 
the gel formulation or a combination of several issues such as temperature, heparin concentration, pH and patient-specific factors. The gel droplets 
were most probably caused by an aberrant gel formulation in combination with an improper storage of the empty tubes on the wards prior to phle-
botomy. After adding an additional instrument cleansing cycle and changing to another batch of heparin tubes the problems could be significantly 
reduced.
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Pre-analytical mysteries
Introduction
With this case report we want to highlight a pre-
analytical issue, potentially leading to instrument 
pipette clogging and/or deviated analysis results 
due to incorrect sample volume aspiration. We be-
lieve that it is more frequent than commonly an-
ticipated and that it is of great importance, espe-
cially for high throughput laboratories using prima-
ry samples on their analysers. For laboratories deal-
ing with similar issues, this report might be helpful 
to overcome similar problems more quickly.
Laboratory analyses
Our laboratory encountered the following analyti-
cal problem using the COBAS Modular P system 
(Roche Diagnostics, Rotkreuz, Switzerland). A hep-
arin-plasma sample with a separator gel was col-
lected from a patient and centrifuged at 2000 g for 
10 minutes after being sent to our laboratory by a 
pneumatic tube system. Total transportation time 
of this sample was only 8 minutes. Subsequently 
the values presented in Table 1 were measured.
Further investigation
As a glucose value of 0.06 mmol/L (1 mg/dL) was 
clinically implausible, the value was re-measured 
from the same sample, yielding a glucose level of 
5.4 mmol/L (97 mg/dL). Initially, we investigated 
potential analytical errors for this discrepancy, but 
as the internal and external quality assurance val-
ues were all on target in high and low levels and 
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glucose values of other patient samples were all 
inconspicuous, we started to investigate potential 
pre-analytical errors. While investigating the tube 
more closely, we noticed clotted white material as 
well as fat droplets floating on the surface of the 
sample (Figure 1). Similar observations were made 
in a small number of additional heparin-gel-tubes 
of other patients. In some of these tubes we found 
either fat droplets or white clots (Figure 2) and in 
some we found a combination of both. Some of 
the white clots were visible by the naked eye 
whereas others could only be detected with a dig-
ital microscope camera including a light source.
Solution
After staining the white clots with a May-Grün-
wald-Giemsa stain and evaluating them under the 
microscope, we identified it as a conglomerate of 
fibrinogen, platelets (PLT) and some leukocytes 
(WBC), described as “white particulate matter” 
(WPM). The fat droplets most probably originated 
from the separator gel in the tubes. We concluded 
that these structures floating on the surface of the 
heparin tubes were sufficient to form a temporary 
clot in the pipetting needle, whereby the sam-
pling volume was significantly altered. As a result 
of this deviation, glucose measurement, which 
only needs 2 µL of plasma, was affected accord-
ingly. After adding an additional instrument rou-
tine cleansing cycle throughout the day and an ex-
change to another heparin tube batch we were 
able to reduce these issues to a minimum.    
Discussion
We report a case where gel droplets as well as 
white particulate matter on the surface of heparin 
gel tubes altered routine clinical chemistry analy-
ses. The formation of so called white particulate 
matter is a phenomenon which was primarily de-
scribed in red blood cell units (1-5). In 2003, WPM 
was detected in blood preparations collected into 
Terumo blood-collection bags. Bright field and dif-
ferential interference contrast microscopy re-
vealed that they consisted of cellular debris, WBCs, 
PLTs, and a few fibrin strands surrounded by eryth-
rocytes. As the United States Food and Drug ad-
ministration did not conclusively rule out a poten-
tial association between WPM formation in blood 
units and some adverse events, blood units had to 
be monitored and be quarantined in case of WPM 
Figure 1. White particulate matter as well as gel droplets float-
ing on the surface of a heparin-plasma tube (picture taken with 
a USB microscope camera). 
Figure 2. White particulate matter floating on the surface of 
a heparin-plasma tube (picture taken with a USB microscope 
camera).
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appearance (6). In one letter from Dimeski et al., 
appearance of WPM is mentioned in routine sam-
ples for clinical chemistry analyses (7). They report 
intermittent duplicate errors in lactate dehydroge-
nase measurements using lithium-heparin gel 
tubes on a Hitachi device due to microclots con-
sisting of leukocytes, erythrocytes, platelets and 
fibrinogen, causing sampling errors, similar to the 
ones we report here. The authors refer to 4 to 8% 
of all heparin-gel tubes containing WPM, depend-
ing on the tube manufacturer. They attribute the 
analytical interference of WPM to several condi-
tions: 
1) WPM may cause sampling problems especially 
in low volume tests as they are detected as part 
of the total volume. This fits to our finding of 
an altered glucose value for which only 2 µl of 
plasma is used. 
2) If cellular components of the WPM rupture, 
they might release intracellular components al-
tering the sample composition. 
3) If intact WPM is transferred into the reaction cu-
vette, it might interfere with the optical system. 
The authors consider the gel formulation of the re-
spective tube to be responsible for the formation 
of these microclots. Patel et al., however, suggest-
ed that high speed centrifugation and high cho-
lesterol levels might cause WPM (8). Since WPM is 
primarily detectable in heparin tubes, this antico-
agulant most probably is one of the causing 
agents. Also other parts of the pre-analytical pro-
cess such as transport or centrifugation conditions 
or the time from blood collection until centrifuga-
tion could be contributing factors. We believe 
however, that a combination of more than one in-
fluencing factor is the reason for WPM formation. 
Such factors might include temperature, pH, the 
filling grade of the tube and the subsequently al-
tered final heparin concentration or patient specif-
ic factors related to their medical condition. To in-
vestigate this topic, a rather elaborate study would 
be needed to address all these possibilities. 
In our case not only WPM was present but also fat 
droplets on the plasma surface, most probably 
originating from the separator gel. After casual 
analysis, we concluded that they formed due to an 
aberrant gel formulation of the respective tube 
batch in combination with inadequate storage of 
the empty tubes at high temperatures on the 
wards prior to phlebotomy, thereby releasing 
small amounts of gel components from the gel 
plug. These droplets then adhered to the inner 
surface of the pipetting needle and as the gel for-
mations were also found in other clinical samples, 
an incremental occlusion was the result.
Not all laboratories will experience this problem 
depending on their equipment and set up. The 
reasons for this are that either the number of tubes 
processed between two instrument cleansing cy-
cles is too small to form plaques on the pipetting 
needle, or they used a pre-analytical system for ali-
quoting plasma prior to analytics. Thereby WPM 
Parameter Unit Value Measurement #1 Value Measurement #2 Reference value
Chloride mmol/L 103 / 97 - 108
Potassium mmol/L 4.0 / 3.6 - 5.0
Sodium mmol/L 144 / 135 - 148
Urea mmol/L 4.0 / 2.8 - 8.1
Creatinine µmol/L 70.8 / 62 - 106
Calcium mmol/L 2.28 / 2.13 - 2.63
Glucose mmol/L 0.06 5.4 3.9 - 5.6
CRP mg/L < 6 / < 6
CRP – C reactive protein.
Table 1. Measurements of case sample
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and gel droplets bound to the disposable pipette 
tip from the pre-analytics module got discarded 
before being transported to the analytical instru-
ments. This theory was strengthened by the fact 
that WPM was not of concern in the immunology 
module of the COBAS instruments (E-Module) 
which also uses disposable pipette tips for sam-
pling. In contrast to the above mentioned labora-
tories, all measurements in our clinical chemistry 
department were performed from primary sample 
tubes without any pre-analytical handling except 
centrifugation and decapping, thereby exposing 
the analytical instrument directly to the interfering 
substances. 
What you should / can do in your laboratory to 
prevent such errors
For those laboratories who encounter similar 
problems as the ones we describe, we suggest: 
•	 adding additional routine cleansing procedures 
to the instrument, 
•	 changing to another heparin tube batch, 
•	 instructing the wards on how to store blood 
collection tubes properly, or 
•	 adding an aliquotation step prior to transporta-
tion to the analytical unit.
•	 If this doesn’t resolve the issue, the use of se-
rum samples instead of heparin plasma sam-
ples might be helpful as WPM in these tubes is 
found at much lower rates (7). 
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